Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1996 | 1 |
2017 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.
N Engl J Med. 2017.
PMID: 28121498
Free article.
Clinical Trial.
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.
Sims MD, Khanna S, Feuerstadt P, Louie TJ, Kelly CR, Huang ES, Hohmann EL, Wang EEL, Oneto C, Cohen SH, Berenson CS, Korman L, Lee C, Lashner B, Kraft CS, Ramesh M, Silverman M, Pardi DS, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L; ECOSPOR IV Investigators.
Sims MD, et al. Among authors: kelly cr.
JAMA Netw Open. 2023 Feb 1;6(2):e2255758. doi: 10.1001/jamanetworkopen.2022.55758.
JAMA Netw Open. 2023.
PMID: 36780159
Free PMC article.
Clinical Trial.
Item in Clipboard
Inner-city adults with severe reading difficulties: a closer look.
Gottesman RL, Bennett RE, Nathan RG, Kelly MS.
Gottesman RL, et al. Among authors: kelly ms, nathan rg.
J Learn Disabil. 1996 Nov;29(6):589-97. doi: 10.1177/002221949602900603.
J Learn Disabil. 1996.
PMID: 8942303
Item in Clipboard
Cite
Cite